Burzynski Research Institute, Inc.
Burzynski Research Institute, Inc.
Your view on BZYR
Overview
What the company does, where it operates, and who runs it.
About Burzynski Research Institute, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Stanislaw R. Burzynski
- Headquarters
- 9432 Katy Freeway, Houston, TX, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Stanislaw R. Burzynski
- Headquarters
- 9432 Katy Freeway, Houston, TX, US
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. The company is also involved in the production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.